Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.

J Infect Dis. 2008 Sep 1;198(5):635-41. doi: 10.1086/590916.

PMID:
18694338
3.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
4.

Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.

Palache AM, Beyer WE, Lüchters G, Völker R, Sprenger MJ, Masurel N.

Vaccine. 1993;11(9):892-908. Review.

PMID:
8212834
5.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
6.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Vajo Z.

Expert Rev Vaccines. 2009 May;8(5):619-24. doi: 10.1586/erv.09.25. Review.

PMID:
19397418
7.

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.

Luke CJ, Subbarao K.

Expert Rev Vaccines. 2014 Jul;13(7):873-83. doi: 10.1586/14760584.2014.922416. Epub 2014 May 23. Review.

PMID:
24855993
8.

[Specific prophylaxis of influenza with inactivated split vaccine Vaxigrip].

Semenenko TA, Sel'kova EP, Gendon IuZ.

Zh Mikrobiol Epidemiol Immunobiol. 2004 Jul-Aug;(4):109-14. Review. Russian.

PMID:
15481939
9.

The use of inactivated influenza vaccine in children.

Wright PF.

Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. Review.

PMID:
17055371
10.

Reduced-dose influenza vaccine.

Wyatt KN, Ryan GJ, Sheerin KA.

Ann Pharmacother. 2006 Sep;40(9):1635-9. Epub 2006 Jul 11. Review.

PMID:
16835314
11.

Changing perspective on immunization against influenza.

Johansson BE, Brett IC.

Vaccine. 2007 Apr 20;25(16):3062-5. Epub 2007 Jan 19. Review.

PMID:
17276554
12.

Recent changes in influenza vaccination recommendations, 2007.

Zimmerman RK.

J Fam Pract. 2007 Feb;56(2 Suppl Vaccines):S12-7, C1. Review.

PMID:
17270107
13.

Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children.

Nakayama T, Kumagai T, Ishii KJ, Ihara T.

Vaccine. 2012 Dec 14;30(52):7662-6. doi: 10.1016/j.vaccine.2012.10.006. Epub 2012 Oct 24. Review.

PMID:
23102974
14.

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.

Safdar A, Cox MM.

Expert Opin Investig Drugs. 2007 Jul;16(7):927-34. Review.

PMID:
17594180
15.
16.

Immunogenicity and protective efficacy of influenza vaccination.

Hannoun C, Megas F, Piercy J.

Virus Res. 2004 Jul;103(1-2):133-8. Review. No abstract available.

PMID:
15163501
17.

Development of pandemic influenza vaccine production capacity in Viet Nam.

Hoa LK, Hiep LV, Be LV.

Vaccine. 2011 Jul 1;29 Suppl 1:A34-6. doi: 10.1016/j.vaccine.2011.04.118. Review.

18.

Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines.

Vankerckhoven V, Van Damme P.

Expert Opin Drug Deliv. 2010 Sep;7(9):1109-25. doi: 10.1517/17425247.2010.507668. Review.

PMID:
20716021
19.

Immunosenescence: role and measurement in influenza vaccine response among the elderly.

Targonski PV, Jacobson RM, Poland GA.

Vaccine. 2007 Apr 20;25(16):3066-9. Epub 2007 Jan 16. Review.

PMID:
17275144
20.

Use of combined viral vaccines.

Gallili GE.

Adv Biotechnol Processes. 1990;14:147-57. Review. No abstract available.

PMID:
2222832

Supplemental Content

Support Center